Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.32 |
| ▸ | GALR3 | O60755 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | SOAT2 | O75908 | 1/20 | 0.31 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4195109 | 0.83 | TSHR (0.36) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL4299637 | 0.76 | — | — | |
| SCHEMBL10410246 | 0.69 | — | — | |
| SCHEMBL2962559 | 0.67 | TSHR (0.32) | TSHR | |
| SCHEMBL10617924 | 0.64 | — | — | |
| SCHEMBL16969557 | 0.63 | — | — | |
| SCHEMBL18074210 | 0.63 | TSHR (0.53) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL4611710 | 0.61 | — | — | |
| SCHEMBL4611078 | 0.61 | — | — | |
| SCHEMBL10782810 | 0.61 | TSHR (0.50) | TSHRCHRM2CHRM4CHRM1TBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2094090-B1 | SYNERGISTIC MICROBICIDAL COMPOSITIONS INCLUDING A CYANODITHIOCARBIMATE AND A SECOND MICROBICIDE, AND METHODS OF USING THE SAME | BUCKMAN LABOR INC (US) | 2015-03-11 | — | — | EP | disclosed |
| EP-2385759-A2 | MICROBICIDAL COMPOSITIONS INCLUDING ACTIVATED NITROGENOUS COMPOUND AND 1,4-BIS (BROMOACETOXY)-2-BUTENE, AND METHODS OF USING THE SAME | BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) | 2011-11-16 | — | — | EP | disclosed |
| US-D647205-S1 | Control unit | HU-FRIEDY MFG. CO., INC. (US) | 2011-10-18 | — | — | US | disclosed |
| US-7772156-B2 | Microbicidal compositions including a cyanodithiocarbimate and a second microbicide, and methods of using the same | BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) | 2010-08-10 | — | — | US | disclosed |
| WO-2010080305-A2 | MICROBICIDAL COMPOSITIONS INCLUDING ACTIVATED NITROGENOUS COMPOUND AND 1,4-BIS (BROMOACETOXY)-2-BUTENE, AND METHODS OF USING THE SAME | BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) | 2010-07-15 | — | — | WO | disclosed |
| US-20100173018-A1 | Microbicidal Compositions Including Activated Nitrogenous Compound and 1,4-Bis(Bromoacetoxy)-2-Butene, and Methods Of Using The Same | BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) | 2010-07-08 | — | — | US | disclosed |
| US-20080102094-A1 | Microbicidal Compositions Including A Cyanodithiocarbimate And A Second Microbicide, And Methods of Using The Same | BUCKMAN LABORATORIES INTERNATIONAL, INC. | 2008-05-01 | — | — | US | disclosed |
| EP-0835054-B1 | EMULSIFIED COMPOSITIONS OF 1,4-BIS(BROMOACETOXY)-2-BUTENE USEFUL AS A MICROBICIDE AND PRESERVATIVE | BUCKMAN LABOR INC (US) | 2001-09-19 | — | — | EP | disclosed |
| EP-0835054-A1 | EMULSIFIED COMPOSITIONS OF 1,4-BIS(BROMOACETOXY)-2-BUTENE USEFUL AS A MICROBICIDE AND PRESERVATIVE | BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) | 1998-04-15 | — | — | EP | disclosed |
| US-5681851-A | BACTERICIDE, FUNGICIDE | BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) | 1997-10-28 | — | — | US | disclosed |
| WO-1996039828-A1 | EMULSIFIED COMPOSITIONS OF 1,4-BIS(BROMOACETOXY)-2-BUTENE USEFUL AS A MICROBICIDE AND PRESERVATIVE | BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100173018-A1 | Microbicidal Compositions Including Activated Nitrogenous Compound and 1,4-Bis(Bromoacetoxy)-2-Butene, and Methods Of Using The Same | BBOX1, BLVRB, MAOB | TSHR 4539/4885CHRM2 1673/4885CHRM4 1825/4885 |
| US-20080102094-A1 | Microbicidal Compositions Including A Cyanodithiocarbimate And A Second Microbicide, And Methods of Using The Same | TST, MYD88, AADAC | TSHR 2289/4885CHRM2 2361/4885CHRM4 1752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.